Edge Wealth Management LLC Editas Medicine, Inc. Transaction History

Edge Wealth Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 21, 2020	SELL	$28.06 - $37.16 $701 - $928	-25 Closed	0 $0
Q2 2020 Aug 03, 2020	SELL	$18.5 - $34.34 $3,552 - $6,593	-192 Reduced 88.48%	25 $1,000
Q1 2020 Apr 20, 2020	SELL	$14.88 - $32.78 $98,327 - $216,610	-6,608 Reduced 96.82%	217 $4,000
Q4 2019 Jan 29, 2020	SELL	$19.49 - $32.63 $4,092 - $6,852	-210 Reduced 2.99%	6,825 $203,000
Q4 2018 Jan 11, 2019	BUY	$18.19 - $31.79 $127,966 - $223,642	7,035 New	7,035 $160,000

252

58.7M

494K

417K

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $234M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

Get notified when there are updates to the investment portfolio of Edge Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Edge Wealth Management LLC with notifications on news.